Financed by EU fonds
Laboratory equipment
Laboratory technician working with microscope

20

Years of Research Experience

Innovative Solutions

Welcome to Genera Research

We are the trusted experts

Genera Research Ltd. is a clinical-stage biotechnology company founded in Croatia and is developing recombinant human Bone Morphogenetic Protein (BMP) based products for use in the tissue regeneration and treatment of orthopaedic, spinal, and dental reconstructive procedures.
  • Bone Morphogenetic Proteins
  • Translational and Clinical Research
  • Drug development
Research Experts

Meet Our Management Team

Dora Adanić

COO & CFO

Tamara Božić

Quality Chief
Muhamed Catic

Muhamed Čatić

Founding Advisor
Roland Zonai

Roland Zonai

Business Development Director / CBO
https://eic.ec.europa.eu/events/eic-info-day-zagreb-croatia-2026-02-18_en
202,
2026

EIC Info Day in Zagreb, Croatia

Croatian Science Foundation (HRZZ), Croatian Agency for SMEs, Innovation and Investment (HAMAG-BICRO), and the Ministry of Science, Education and Youth (MZOM) organised the National Info Day of the Horizon Europe Programme - European Innovation Council (EIC). At the EIC Info Day held in Zagreb on 18 February 2026, Dora Adanić took part as a speaker in a discussion focused on the EIC Accelerator programme and its highly competitive evaluation process. During the session, she shared practical insights on what makes a proposal stand out, the importance of building a strong team alongside breakthrough technology, and how companies should prepare 6–12 months ahead of submission. She also addressed key topics such as risk management, scale-up strategy, competition, and the value of coaching and external feedback when developing a successful application. The discussion concluded with concrete advice for future applicants aiming to secure EIC Accelerator support.


https://osteoprodent.com/
157,
2025

Launch of OSTEOproDENT Project Website: Advancing Personalized Bone Regeneration in Dentistry

OSTEOproDENT—Research and Development of an Advanced Formulation for Alveolar Ridge Augmentation—is a collaborative initiative led by Sartorius Croatia – Libra Elektronik d.o.o. in partnership with Genera Research, the University of Zagreb School of Medicine, and Dental Office Bekavac. The project kicked off on January 13, 2025, and is projected to run through January 12, 2028, with a total budget of €4.67 million (€2.7 million in EU co‑financing)


Images dowloladed from: https://osteoprodent.com/